Cambridge Healthtech Institute Announces its Inaugural Biologics Formulation & Delivery Summit by associate14

VIEWS: 4 PAGES: 2

									Cambridge Healthtech Institute Announces its Inaugural Biologics Formulation &
Delivery Summit

Shaping the Future of Delivering Biotherapeutics - What's on the Horizon, May 5-7,
2014, Boston, MA

Needham, MA, United States., January 16, 2014 -- Cambridge Healthtech Institute (CHI)
today announced it will host its inaugural "Biologics Formulation & Delivery Summit" -
- an international forum for the pharmaceutical and device industries to identify courses
of action in biotherapeutics delivery on May 5-7, 2014 at the World Seaport Trade Center
in Boston, MA. This two-part summit will discuss various formulation and device-based
approaches for designing physiologically relevant, patient friendly, targeted biologics
products.

Part 1: Formulation Strategies for Improved Delivery of Biologics (May 5-6)
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and
Device Strategies is the main theme of this conference with a keynote presentation by
Julia Rashba-Step, Ph.D., Senior Director, Novel Delivery Technologies, Pfizer, Inc., will
educate the audience on the future trends on biotherapeutics and importance of drug
delivery in commercial, clinical differentiation and also the need for enabling
technologies. In addition, strategic plans for current and future delivery reflective of
needs of Pfizer's biotherapeutics portfolio will be discussed.

Part 2: New Technologies for Biologics Delivery and Targeting (May 6-7) Driving
Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery
Technologies is the main theme of this conference with a keynote presentation by Omid
Farokhzad, M.D., Associate Professor, Laboratory of Nanomedicine and Biomaterials,
Department of Anesthesiology, Brigham and Women's Hospital and Harvard Medical
School, on the design and optimization of polymeric nanoparticles for medical
applications, which formed the foundation for the clinical translation of the first-in-
human targeted and controlled-release nanoparticles, BIND-014 and SEL-068.

Advances in molecular biology and biotechnology have allowed for the large-scale
production of effective and potent biotherapeutic drugs. Major research issues in
protein/peptide delivery include the stabilization of proteins in delivery devices and the
design of appropriate target-specific carriers. "This summit will be an excellent forum for
focused discussions, initiate new collaborations, socialize and interact with colleagues
from around the world who are facing similar challenges and utilizing compelling
strategies. CHI looks forward to adding this Summit to its portfolio of scientific events
scheduled for 2014," states CHI conference director, Nandini Kashyap.

The rest of the summit includes talks by MedImmune, Allergan, Shire, MannKind,
Novartis, Northeastern University, Duke University, to name a few. Plus, delegates may
choose from three interactive short courses geared towards turning their technologies into
successful patient-friendly products. The summit is co-located with PEGS: the essential
protein engineering summit where 1600+ delegates and 100+ exhibitors will be in
attendance. Delegates have access to a shared exhibit hall with the PEGS attendees, joint
exhibit hall reception and networking breaks.

The Summit offers student fellowship awards to full-time graduate students and Ph.D.
candidates. For further information, to apply for a student fellowship, or to register, visit
http://www.healthtech.com/biologics-delivery.

To receive a press pass or arrange an interview with a speaker, email Lisa Scimemi at
lscimemi@healthtech.com.

About Cambridge Healthtech Institute: Cambridge Healthtech Institute (CHI), founded in
1992, is the industry leader in providing superior quality scientific information to eminent
researchers and business experts from top pharmaceutical, biotech, and academic
organizations. Delivering an assortment of resources such as events, reports, publications
and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute
Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing
Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group. For
more information, visit chicorporate.com.

Contact: James Prudhomme Cambridge Healthtech Institute 250 Firste Avenue, Suite 300
Needham, MA 02494 781-972-5400 jprudhomme@healthtech.com
http://www.chicorporate.com

								
To top